Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-06-20T02:33:09.223Z Has data issue: false hasContentIssue false

Catatonia in depressive disorder, more usual than it is supposed to be

Published online by Cambridge University Press:  19 July 2023

R. J. Carrillo Molina*
Affiliation:
Complejo Hospitalario universitario de Jaén, Jaén, Spain
F. Vilchez Español
Affiliation:
Complejo Hospitalario universitario de Jaén, Jaén, Spain
I. Caparros del Moral
Affiliation:
Complejo Hospitalario universitario de Jaén, Jaén, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Catatonia is a psychomotor syndrome characterized by various motor, affective and behavioral symptoms. It can occur as a cause of various underlying organic and psychiatric disorders. In Psychiatric nosology is used to specify a subtype of the disorder underlying.Unlike what was assumed in the past, today it is accepted that catatonia is more frequent in affective disorders than in schizophrenia. But despite this, diagnosis and treatment are still late in affective cases on many occasions.

Objectives

-A case of catatonia is presented to review the diagnostic difficulties that can sometimes entail.-Review treatment algorithm.

Methods

We present the case of a 62-year-old woman, initially diagnosed of major depressive symptoms with psychotic symptoms, showing no response to different treatments, evolving to catatonia, which is diagnosed after screening for neurological and medical diseases.

Results

The patient had an adequate evolution after the withdrawal of antipsychotics and the application of ECT (Electroconvulsive therapy).

Conclusions

- It is important to carry out an adequate screening, because many times the symptoms are caused by medical or neurological diseases.

-Catatonia has a good prognosis with an early treatment, but it may increase the risk of mortality after 5 days from the onset of symptoms.

-It is important to avoid the use of antipsychotics or other dopamine blockers. The use of benzodiazepines and ECT is indicated.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.